U.S. markets close in 5 hours 10 minutes

Health Catalyst, Inc. (HCAT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
39.00+0.10 (+0.26%)
As of 10:50AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close38.90
Bid39.13 x 2200
Ask39.26 x 800
Day's Range37.21 - 39.24
52 Week Range36.90 - 59.50
Avg. Volume425,649
Market Cap2.03B
Beta (5Y Monthly)0.69
PE Ratio (TTM)N/A
EPS (TTM)-3.26
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est62.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for HCAT

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Health Catalyst, Inc
    HQY: Lowering target price to $59.00HEALTHEQUITY INC has an Investment Rating of HOLD; a target price of $59.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • GlobeNewswire

    Health Catalyst to Participate in Upcoming Investor Conferences

    SALT LAKE CITY, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, CFO, and Adam Brown, SVP of Investor Relations and FP&A, will participate in the following upcoming investor conferences: Piper Sandler 33rd Annual Healthcare Conference including a fireside chat presentation and one-on-one meetings on Thursday, December 2, 2021. A

  • PR Newswire

    Health Catalyst Partners with Datavant to Expand Access to Clinical Trials as a Care Option for Patients

    Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data, analytics and technology services to healthcare and life sciences organizations, and Datavant, the leader in helping organizations securely connect health data, today announced a strategic partnership to improve research and care delivery with connected health data.

  • Motley Fool

    Health Catalyst Inc (HCAT) Q3 2021 Earnings Call Transcript

    HCAT earnings call for the period ending September 30, 2021.